1,909 followers
Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic ... https://t.co/iPrQq9VzMe
Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic ... https://t.co/iPrQq9VzMe
Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats. https://t.co/eiui9czK9s
New Research: Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats: The hypoglycaemic target of empagliflozin (EMP), as a novel inhibitor of sodium-glucose cotransporter (SGLT2), is clear.… https://t.co/nGT87XQg